|
|
Home
Search
Study Topics
Glossary
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Cancer Institute (NCI) |
|---|---|
| Information provided by: | National Cancer Institute (NCI) |
| ClinicalTrials.gov Identifier: | NCT00040924 |
Purpose
RATIONALE: Screening tests may help doctors determine which patients are eligible for treatment on clinical trials.
PURPOSE: This clinical trial is screening patients with central nervous system tumors for participation in National Cancer Institute (NCI) clinical trials.
| Condition | Intervention |
|---|---|
|
Brain and Central Nervous System Tumors Lymphoma |
Procedure: cytology specimen collection procedure Procedure: physiologic testing |
| Study Type: | Interventional |
| Study Design: | Screening |
| Official Title: | Eligibility Screening Of Patients With Central Nervous System Tumors For The National Cancer Institute's (NCI) Clinical Research Protocols |
| Estimated Enrollment: | 500 |
| Study Start Date: | April 2002 |
| Estimated Primary Completion Date: | December 2010 (Final data collection date for primary outcome measure) |
OBJECTIVES:
OUTLINE: Patients undergo various diagnostic procedures and clinical testing to determine eligibility for participation in NCI CNS tumor primary clinical research protocols. Patients undergo imaging scans; laboratory testing of blood, cerebrospinal fluid, bone marrow, urine, and other specimens as needed to determine protocol eligibility; and other specific organ function tests.
PROJECTED ACCRUAL: A maximum of 500 patients will be accrued for this study within 5 years.
Eligibility| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
PATIENT CHARACTERISTICS:
Age:
Performance status:
Life expectancy:
Hematopoietic:
Hepatic:
Renal:
Other:
PRIOR CONCURRENT THERAPY:
Biologic therapy:
Chemotherapy:
Endocrine therapy:
Radiotherapy:
Surgery:
Contacts and Locations| United States, Maryland | |
| Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office | Recruiting |
| Bethesda, Maryland, United States, 20892-1182 | |
| Contact: Clinical Trials Office - Warren Grant Magnusen Clinical Center 888-NCI-1937 | |
| Principal Investigator: | Howard A. Fine, MD | NCI - Neuro-Oncology Branch |
More Information
| Study ID Numbers: | CDR0000069420, NCI-02-C-0186 |
| Study First Received: | July 8, 2002 |
| Last Updated: | December 11, 2008 |
| ClinicalTrials.gov Identifier: | NCT00040924 |
| Health Authority: | Unspecified |
|
prolactin secreting adenoma childhood infratentorial ependymoma childhood low-grade cerebral astrocytoma childhood supratentorial ependymoma childhood craniopharyngioma childhood central nervous system germ cell tumor recurrent adult brain tumor ACTH-producing pituitary tumor prolactin-producing pituitary tumor growth hormone-producing pituitary tumor recurrent pituitary tumor TSH producing pituitary tumor nonfunctioning pituitary tumor adult brain stem glioma adult craniopharyngioma |
adult medulloblastoma adult meningioma adult glioblastoma pituitary basophilic adenoma pituitary eosinophilic adenoma TSH secreting adenoma pituitary chromophobe adenoma childhood high-grade cerebral astrocytoma childhood oligodendroglioma adult anaplastic astrocytoma childhood choroid plexus tumor childhood grade I meningioma childhood grade II meningioma childhood grade III meningioma adult oligodendroglioma |
|
Glioblastoma Choroid Plexus Neoplasms Rhabdoid Tumor Neuroectodermal Tumors, Primitive Central Nervous System Neoplasms Pituitary Neoplasms Ependymoma Central nervous system lymphoma, primary Craniopharyngioma Neuroepithelioma Meningioma Glioma Choroid Plexus neoplasms Lymphoma Nervous System Neoplasms |
Immunoproliferative Disorders Spinal cord neoplasm Astrocytoma Prolactinoma Hemangiopericytoma Recurrence Rhabdoid tumor Lymphatic Diseases Neuroectodermal Tumors Brain Neoplasms Medulloblastoma Spinal Cord Neoplasms Oligodendroglioma Gliosarcoma Lymphoproliferative Disorders |
|
Neoplasms Neoplasms by Site Neoplasms by Histologic Type Immune System Diseases Nervous System Diseases |
